Radiofluorinated rhenium cyclized α-MSH analogues for PET imaging of melanocortin receptor 1

Bioconjugate Chemistry

Volumn 21, Issue 12, 2010, Pages 2355-2360

  Ren, Gang ^a   Liu, Shuanlong ^a   Liu, Hongguang ^a   Miao, Zheng ^a   Cheng, Zhen ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERMEDIN; MELANOCORTIN 1 RECEPTOR; METALLOPROTEIN; RADIOPHARMACEUTICAL AGENT; RHENIUM; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 1; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 1 FLUOROBENZOATE F 18; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 1 FLUOROPROPIONATE F 18; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 1 FLUOROPROPIONATE F 19; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 2; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 2 FLUOROPROPIONATE F 18; RHENIUM CYCLIZED ALPHA MELANOCYTE STIMULATING HORMONE 2 FLUOROPROPIONATE F 19; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYCLIZATION; DIAGNOSTIC ACCURACY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG TUMOR LEVEL; FLUORINATION; HUMAN; HUMAN CELL; IMAGE QUALITY; IN VIVO STUDY; INTERMETHOD COMPARISON; MALE; MELANOMA; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; SOLID PHASE SYNTHESIS; TUMOR XENOGRAFT;

ANIMALIA; MURINAE; MUS;

EID: 78650378812     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc100391a     Document Type: Article

References (30)

1. Gray-Schopfer, V., Wellbrock, C., and Marais, R. (2007) Melanoma biology and new targeted therapy Nature 445, 851-857
2. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics CA Cancer J. Clin. 60, 277-300
3. Rohren, E. M., Turkington, T. G., and Coleman, R. E. (2004) Clinical applications of PET in oncology Radiology 231, 305-32
4. Belhocine, T. Z., Scott, A. M., Even-Sapir, E., Urbain, J. L., and Essner, R. (2006) Role of nuclear medicine in the management of cutaneous malignant melanoma J. Nucl. Med. 47, 957-967
5. Siegrist, W., Solca, F., Stutz, S., Giuffre, L., Carrel, S., Girard, J., and Eberle, A. N. (1989) Characterization of receptors for alpha-melanocyte- stimulating hormone on human melanoma cells Cancer Res. 49, 6352-6358
6. Siegrist, W., Stutz, S., and Eberle, A. N. (1994) Homologous and heterologous regulation of alpha-melanocyte-stimulating hormone receptors in human and mouse melanoma cell lines Cancer Res. 54, 2604-2610
7. Ren, G., Pan, Y., and Cheng, Z. (2010) Molecular probes for malignant melanoma imaging Curr. Pharm. Biotechnol. 11, 590-602
8. Miao, Y. and Quinn, T. (2008) Peptide-targeted radionuclide therapy for melanoma Crit. Rev. Oncol. Hematol. 67, 213-228
9. Froidevaux, S., Calame-Christe, M., Tanner, H., and Eberle, A. N. (2005) Melanoma targeting with DOTA-alpha-melanocyte-stimulating hormone analogs: structural parameters affecting tumor uptake and kidney uptake J. Nucl. Med. 46, 887-895
10. Froidevaux, S., Calame-Christe, M., Tanner, H., Sumanovski, L., and Eberle, A. N. (2002) A novel DOTA-alpha-melanocyte-stimulating hormone analog for metastatic melanoma diagnosis J. Nucl. Med. 43, 1699-1706
11. 64Cu-labeled alpha-melanocyte-stimulating hormone analog for microPET imaging of melanocortin 1 receptor expression Bioconjugate Chem. 18, 765-772 (Pubitemid 47010796)
12. Cheng, Z., Zhang, L., Graves, E., Xiong, Z., Dandekar, M., Chen, X., and Gambhir, S. S. (2007) Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog J. Nucl. Med. 48, 987-994 (Pubitemid 46909928)
13. Chen, J., Cheng, Z., Hoffman, T. J., Jurisson, S. S., and Quinn, T. P. (2000) Melanoma-targeting properties of 99mtechnetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues Cancer Res. 60, 5649-5658
14. Chen, J., Cheng, Z., Owen, N. K., Hoffman, T. J., Miao, Y., Jurisson, S. S., and Quinn, T. P. (2001) Evaluation of an 111In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties J. Nucl. Med. 42, 1847-1855
15. Cheng, Z., Chen, J., Miao, Y., Owen, N. K., Quinn, T. P., and Jurisson, S. S. (2002) Modification of the structure of a metallopeptide: synthesis and biological evaluation of 111In-labeled DOTA-conjugated rhenium-cyclized alpha-MSH analogues J. Med. Chem. 45, 3048-3056
16. Cheng, Z., Chen, J., Quinn, T. P., and Jurisson, S. S. (2004) Radioiodination of rhenium cyclized alpha-melanocyte-stimulating hormone resulting in enhanced radioactivity localization and retention in melanoma Cancer Res. 64, 1411-1418
17. 11), a cyclized peptide analogue of alpha-MSH J. Med. Chem. 48, 2985-2992
18. Giblin, M. F., Wang, N., Hoffman, T. J., Jurisson, S. S., and Quinn, T. P. (1998) Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination Proc. Natl. Acad. Sci. U.S.A. 95, 12814-12818
19. Ren, G., Liu, Z., Miao, Z., Liu, H., Subbarayan, M., Chin, F. T., Zhang, L., Gambhir, S. S., and Cheng, Z. (2009) PET of malignant melanoma using 18F-labeled metallopeptides J. Nucl. Med. 50, 1865-1872
20. Liu, S., Shen, B., Chin, F., and Cheng, Z. (2010) Recent progress in radiofluorination of peptides for PET molecular imaging. Curr. Org. Synth., in press.
21. Guhlke, S., Coenen, H. H., and Stöcklin, G. (1994) Fluoroacylation agents based on small n.c.a. 18F-fluorocarboxylic acids Appl. Radiat. Isot. 45, 715-727
22. Haubner, R., Kuhnast, B., Mang, C., Weber, W. A., Kessler, H., Wester, H. J., and Schwaiger, M. (2004) 18F-Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates Bioconjugate Chem. 15, 61-69
23. Beer, A. J., Haubner, R., Sarbia, M., Goebel, M., Luderschmidt, S., Grosu, A. L., Schnell, O., Niemeyer, M., Kessler, H., Wester, H. J., Weber, W. A., and Schwaiger, M. (2006) Positron emission tomography using 18F-Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man Clin. Cancer Res. 12, 3942-3949
24. Liu, S., Liu, Z., Chen, K., Yan, Y., Watzlowik, P., Wester, H. J., Chin, F. T., and Chen, X. (2010) 18F-labeled galacto and PEGylated RGD dimers for PET imaging of α(v)β (3) integrin expression. Mol Imaging Biol. 12, 530-538.
25. Haubner, R., Kuhnast, B., Mang, C., Weber, W. A., Kessler, H., Wester, H. J., and Schwaiger, M. (2004) 18F-Galacto-RGD: synthesis, radiolabeling, metabolic stability, and radiation dose estimates Bioconjugate Chem. 15, 61-69
26. Benjamin, C. L., Melnikova, V. O., and Ananthaswamy, H. N. (2007) Models and mechanisms in malignant melanoma Mol. Carcinog. 46, 671-678
27. Bohm, M., Luger, T. A., Tobin, D. J., and Garcia-Borron, J. C. (2006) Melanocortin receptor ligands: new horizons for skin biology and clinical dermatology J. Invest. Dermatol. 126, 1966-1975
28. Liu, S. (2009) Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency Bioconjugate Chem. 20, 2199-2213
29. Lee, S., Xie, J., and Chen, X. (2010) Peptides and peptide hormones for molecular imaging and disease diagnosis Chem. Rev. 110, 3087-3111
30. Lewis, J. S. and Anderson, C. J. (2007) Radiometal-labeled somatostatin analogs for applications in cancer imaging and therapy Methods Mol. Biol. 386, 227-240